38 /100
MEDIUM RISK
Score updated Apr 13, 2026

LCTX

Lineage Cell Therapeutics, Inc. — Stock Dilution Tracker

Track LCTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track LCTX — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
65
💰 Cash Runway
0
📊 Float Risk
27
⚠️ Warrant Exposure
50
🔄Convertible Debt
🌦️ Dilution Forecast
Watch
Minor dilution signals detected
33%
💰 Capital Raise 38%
• Active shelf registration ($100M, 27% of market cap)
• Active ATM program with $37M remaining capacity
🔄 Reverse Split 30%
• 50-day avg $1.67 approaching $1 threshold
📜 Warrant Exercise 25%
• Significant warrants: 16% of shares outstanding
🔔 Track LCTX — Get forecast alerts →
💹 Market Data
Market Cap$368.65M
Shares Outstanding249.09M
Float187.07M
Cash$55.78M
Debt$2.42M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 13.9% shares (2025Q4 vs prior)
123 institutional holders · 102.18M shares
#1 BROADWOOD CAPITAL INC 49.56M shares
#2 VANGUARD GROUP INC 9.64M shares
#3 Defender Capital, LLC. 6.83M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest25.47M
Days to Cover22.3
% of Float13.6%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2017
EFFECT EFFECT Mar 23, 2026
4 INSIDER TRANSACTION Mar 12, 2026
S-3 SHELF Mar 11, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track LCTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LCTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required